Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models

References

• Bogaerts H. The future of childhood immunizations: examining the European experience. Am J Manag Care. 2003;9(1 Suppl):S30–12. doi:10.1023/A:1023536527428.
   PubMed Web of Science ®Google Scholar
• Koslap-Petraco MB, Judelsohn RG. Societal impact of combination vaccines: experiences of physicians, nurses, and parents. J Pediatr Health Care. 2008;22(5):300–09. doi:10.1016/j.pedhc.2007.09.004.
   PubMed Web of Science ®Google Scholar
• Wenger J. Vaccines for the developing world: current status and future directions. Vaccine. 2001;19(13–14):1588–91. doi:10.1016/s0264-410x(00)00356-x.
   PubMed Web of Science ®Google Scholar
• Bar-On ES, Goldberg E, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane Database Syst Rev. 2012;4:CD005530. doi:10.1002/14651858.CD005530.pub3.
   Google Scholar
• Stanley AP, Walter AO, Paul AO, Kathryn ME. Section 2: Licensed Vaccines and Vaccines in Develpment. 15. Combination vaccines. Plotkin’s vaccines. 7th ed. Philadelphia, PA: Elsevier; 2017.
   Google Scholar
• Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J. 2006;25(6):507–12. doi:10.1097/01.inf.0000222413.47344.23.
   PubMed Web of Science ®Google Scholar
• Marshall GS, Happe LE, Lunacsek OE, Szymanski MD, Woods CR, Zahn M, Russell A. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26(6):496–500. doi:10.1097/INF.0b013e31805d7f17.
   PubMed Web of Science ®Google Scholar
• Meyerhoff A, Jacobs RJ, Greenberg DP, Yagoda B, Castles CG. Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE study (Combination vaccines impact on satisfaction and epidemiology). Clin Pediatr (Phila). 2004;43(1):87–93. doi:10.1177/000992280404300112.
   PubMed Web of Science ®Google Scholar
• Woodin KA, Rodewald LE, Humiston SG, Carges MS, Schaffer SJ, Szilagyi PG. Physician and parent opinions. Are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med. 1995;149(8):845–49. doi:10.1001/archpedi.1995.02170210019003.
   PubMedGoogle Scholar
• Sara E, Oliver MD, Kelly L, Moore MD. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and guidance for use in infants. MMWR. 2020 Feb 7;69(5):136–39. doi:10.15585/mmwr.mm6905a5.
   PubMed Web of Science ®Google Scholar
• WHO recommendations for routine immunization-summary tables; 2021 Nov. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/who-recommendations-for-routine-immunization—summary-tables.
   Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for industry for the evaluation of combination vaccines for preventable diseases: production, testing and clinical studies; 1997 Apr. https://www.fda.gov/media/77191/download.
   Google Scholar
• Vaccine Administration Law of the People’s Republic of China. Chapter I general provisions article 14. 2019.
   Google Scholar
• Zheng J, Liu D. Chinese Prevention Medicine Association. Chinese preventive medicine association technical guide for the application of acellular diabetic, inactivated polio and Haemophilus influenzae (conjugate) combined vaccine (DTaP-IPV/Hib five-unit vaccine). South China J Prev Med. 2011; 37(2): 67–74.
   Google Scholar
• Center for Drug Evaluation, China National Medical Products Administration. Guidelines. Technical guidelines for preclinical and clinical studies of combined vaccines; 2005 Oct 14. https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=0e94e3802cf31d2434d4a387b4cee4c5.
   Google Scholar
• Wang LC, Chao Z, Wei C, Yan W, Luo P, Ma X. Analysis of immune responses induced in mice by two different types of acellular pertussis vaccines. Prog Microbiol Immunol. 2018;46(4):14–18. doi:10.13309/j.cnki.pmi.2018.04.003.
   Google Scholar
• Center for Drug Evaluation, NMPA. Technical guidelines of drug irritation, sensitization and hemolytic study; [accessed 2020 Dec 10]. http://www.cde.org.cn/zdyz.do?method=largePage&id=188.
   Google Scholar
• Forster R. Study designs for the nonclinical safety testing of new vaccine products. J Pharmacol Toxicol Methods. 2012;66(1):1–7. doi:10.1016/j.vascn.2012.04.003.
   PubMed Web of Science ®Google Scholar
• Levast B, Schulz S, Hurk S, Gerdts V. Animal models for neonatal diseases in humans. Vaccine. 2013;31(21):2489–99. doi:10.1016/j.vaccine.2012.11.089.
   PubMed Web of Science ®Google Scholar
• Golding H, Khurana S, Zaitseva M. What is the predictive value of animal models for vaccine efficacy in humans? The importance of bridging studies and species-independent correlates of protection. Cold Spring Harb Perspect Biol. 2018;10(4):a028902. doi:10.1101/cshperspect.a028902.
   PubMed Web of Science ®Google Scholar
• Baldrick P. Dose site reactions and related findings after vaccine administration in safety studies. J Appl Toxicol. 2016;36(8):980–90. doi:10.1002/jat.3314.
   PubMed Web of Science ®Google Scholar
• Hogenesch H. Mechanism of immunopotentiation and safety of aluminum adjuvants. Front Immunol. 2012;3:406. doi:10.3389/fimmu.2012.00406.
   PubMed Web of Science ®Google Scholar
• Lindblad EB. Aluminium compounds for use in vaccines. Immunol Cell Biol. 2004;82(5):497–505. doi:10.1111/j.0818-9641.2004.01286.x.
   PubMed Web of Science ®Google Scholar
• Gherardi RK, Aouizerate J, Cadusseau J, Yara S, Authier FJ. Aluminum adjuvants of vaccines injected into the muscle: normal fate, pathology and associated disease. Morphologie. 2016;100(329):85–94. doi:10.1016/j.morpho.2016.01.002.
   PubMedGoogle Scholar
• Plotkin SA, Liese J, Madhi SA, Ortiz E. A DTaP–IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years’ clinical experience. Expert Rev Vaccines. 2011;10(7):981–1005. doi:10.1586/erv.11.72.
   PubMed Web of Science ®Google Scholar